ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1528522

This article is part of the Research TopicMolecular Mechanisms and Therapeutic Strategies in InflammationView all 15 articles

Intrauterine infusion of autologous platelet-rich plasma modulates endometrial immune status and improves pregnancy outcomes in patients with persistent chronic endometritis

Provisionally accepted
Xian  ChenXian Chen1*Mingye  ChenMingye Chen1Meng  LiuMeng Liu1Lingbin  QiLingbin Qi2Zhiqiang  LiuZhiqiang Liu1Cong  ChenCong Chen3Binfa  LiangBinfa Liang1Xiaobing  YangXiaobing Yang1Tao  ZhangTao Zhang4Yuye  LiYuye Li1*Ruochun  LianRuochun Lian1*
  • 1Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zhongshan Urology Hospital), Shenzhen, China, Shenzhen, China
  • 2School of Medicine, Tongji University, Shanghai, Shanghai Municipality, China
  • 3Guangdong Medical University, Zhanjiang, Guangdong, China
  • 4The Chinese University of Hong Kong, Shatin, Hong Kong Region, China

The final, formatted version of the article will be published soon.

Background: Chronic endometritis (CE) has been widely recognized as a potential cause of infertility, however, access to effective treatment is a formidable challenge due to the rudimentary understanding of the pathogenesis of persistent CE. Here, we aimed to analyze the impact of platelet-rich plasma (PRP) treatment on pregnancy outcomes and the endometrial microenvironment in patients with persistent CE.Methods: A total of 89 infertility patients were selected, including 56 non-CE (as the control group) and 33 persistent CE. The persistent CE patients received an intrauterine infusion of PRP four times before embryo transfer. Immunohistochemistry staining and transcriptomic sequencing were used to investigate the uterine-specific role of PRP in patients with persistent CE.The implantation rate and clinical pregnancy rate were significantly increased in the cured CE group compared to the non-cured CE group. After PRP treatment, the proportions of endometrial CD8 + T cells, CD56 + NK cells, Foxp3 + Treg cells, and T-bet + Th1 cells were significantly decreased in patients with persistent CE. Specifically, DEG analysis showed that genes implicated in endometrial receptivity-related and antimicrobial were upregulated and genes involved in the immune response processes were downregulated in cured CE patients after PRP treatment.Functional enrichment analysis suggested that the effects of changes in leukocyte chemotaxisrelated genes played a critical role in the endometrial immune environment.Conclusions: Autologous PRP treatment has been shown as a potentially successful therapy for improving pregnancy outcomes by reconstructing the uterine local immune microenvironment to improve endometrial receptivity in patients with persistent CE.

Keywords: Chronic endometritis, Platelet-Rich Plasma, pregnancy outcomes, endometrial immune cells, Infertility

Received: 15 Nov 2024; Accepted: 23 Apr 2025.

Copyright: © 2025 Chen, Chen, Liu, Qi, Liu, Chen, Liang, Yang, Zhang, Li and Lian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xian Chen, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zhongshan Urology Hospital), Shenzhen, China, Shenzhen, China
Yuye Li, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zhongshan Urology Hospital), Shenzhen, China, Shenzhen, China
Ruochun Lian, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zhongshan Urology Hospital), Shenzhen, China, Shenzhen, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.